GO:0036409 histone H3-K14 acetyltransferase complex

The histone H3-K14 acetyltransferase complex (GO:0036409) is a cellular component defined by its ability to acetylate lysine 14 of histone H3. This post-translational modification, H3K14ac, is a well-established mark of active chromatin and plays a central role in regulating gene expression, DNA replication, and repair. Understanding the composition and regulation of this complex is essential for deciphering how cells control chromatin states and respond to developmental and environmental cues. The complex is part of the broader family of histone acetyltransferase (HAT) complexes, which are conserved from yeast to humans and are critical for epigenetic regulation. Recent studies have revealed that H3K14 acetylation is not an isolated event but is coordinated with other histone modifications, such as H3K56 acetylation, through the histone chaperone Asf1. This crosstalk underscores the importance of the H3-K14 acetyltransferase complex in maintaining genomic integrity and proper gene expression programs. Researchers studying chromatin biology, cancer epigenetics, and transcriptional regulation are increasingly focused on this complex as a potential target for therapeutic intervention.

GO:0036409, histone H3-K14 acetyltransferase complex, is a protein complex that catalyzes the acetylation of lysine at position 14 in histone H3. This enzymatic activity transfers an acetyl group from acetyl-CoA to the ε-amino group of H3K14, resulting in a modified histone that influences chromatin structure and function. The complex is classified under the cellular component ontology, indicating it is a distinct molecular machine within the cell. Its defining biochemical function is the specific acetylation of H3K14, distinguishing it from other HAT complexes with different substrate specificities.

The histone H3-K14 acetyltransferase complex is critical for epigenetic regulation because H3K14 acetylation is associated with open chromatin and active transcription. Its activity influences fundamental processes such as gene expression, DNA replication, and DNA damage repair. Moreover, the complex is integrated into a network of histone modifications, as demonstrated by its crosstalk with H3K56 acetylation via Asf1. This interconnectedness means that perturbations in the complex can have widespread effects on cellular physiology, contributing to diseases like cancer. Therefore, studying this complex provides insights into both normal development and pathological states, and it offers a potential target for epigenetic therapies.

The following genes and proteins are key components or regulators of the histone H3-K14 acetyltransferase complex and its associated functions.

The activity and targeting of the histone H3-K14 acetyltransferase complex are regulated at multiple levels. The complex is recruited to specific chromatin regions by transcription factors and other chromatin modifiers. Its catalytic activity can be modulated by post-translational modifications of its subunits and by interaction with regulatory proteins such as Asf1, which mediates crosstalk between H3K14 and H3K56 acetylation. Additionally, the availability of acetyl-CoA, the acetyl group donor, links cellular metabolism to H3K14 acetylation. Deacetylases such as HDAC1/2 and SIRT1 counteract the complex's activity, ensuring dynamic turnover of the mark.

Dysregulation of histone acetylation, including H3K14 acetylation, is a hallmark of many cancers. Mutations or altered expression of HAT complex subunits, such as EP300, CREBBP, and KAT6A, have been observed in various malignancies. The crosstalk between H3K14 and H3K56 acetylation mediated by Asf1 may contribute to genome instability and tumorigenesis. Targeting the H3-K14 acetyltransferase complex or its readers (e.g., BRD4) is an active area of anticancer drug development.

Mutations in genes encoding HAT complex components, such as CREBBP and KAT6B, are linked to neurodevelopmental disorders like Rubinstein-Taybi syndrome and genitopatellar syndrome. These conditions highlight the critical role of proper H3K14 acetylation in brain development and cognitive function. Understanding the complex's function may provide insights into potential therapeutic strategies.

Histone acetylation, including H3K14ac, plays a role in regulating inflammatory gene expression. The H3-K14 acetyltransferase complex may contribute to the activation of immune cells and the pathogenesis of chronic inflammatory diseases. Modulating its activity could offer therapeutic avenues for inflammatory conditions.

ChIP with antibodies specific to H3K14ac or to tagged complex subunits allows mapping of the complex's binding sites and the distribution of the mark across the genome. This method is essential for understanding how the complex contributes to gene regulation and chromatin architecture.

Affinity purification of the complex followed by mass spectrometry identifies its subunit composition and post-translational modifications. Quantitative proteomics can reveal dynamic changes in complex interactions under different conditions.

In vitro HAT assays using recombinant histones or peptides measure the catalytic activity of the complex and its mutants. These assays are crucial for determining substrate specificity and kinetic parameters.

Genome-wide CRISPR knockout or activation screens can identify genes that regulate H3K14 acetylation levels or that are required for the function of the complex. Such screens link the complex to specific cellular phenotypes and pathways.

Researchers studying histone H3-K14 acetyltransferase complex-related genes often need to determine whether a candidate gene is causally involved in H3K14 acetylation, chromatin regulation, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this functional validation.

The histone H3-K14 acetyltransferase complex (GO:0036409) is a central player in chromatin regulation, with its catalytic activity influencing gene expression, DNA replication, and repair. Its integration into modification crosstalk networks, particularly via Asf1, highlights its importance in cellular physiology and disease. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate its mechanisms and therapeutic potential.